This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kathleen O'Dwyer: Innovator in Protein Characterization
Introduction
Kathleen O'Dwyer is a prominent inventor based in Boher, Limerick, Ireland. She has made significant contributions to the field of biotechnology, particularly in the characterization and purification of proteins. Her work has implications for therapeutic developments and advancements in medical research.
Latest Patents
Kathleen O'Dwyer holds a patent titled "Methods of Characterizing and Purifying VEGF Receptor Fusion Protein." This patent reflects her expertise in protein engineering and her commitment to enhancing the understanding of vascular endothelial growth factor (VEGF) receptors.
Career Highlights
Kathleen is currently employed at Regeneron Pharmaceuticals, Inc., where she applies her knowledge and skills to advance biopharmaceutical innovations. Her work at Regeneron has positioned her as a key player in the development of novel therapies.
Collaborations
Throughout her career, Kathleen has collaborated with notable colleagues, including Paul Conroy and John Crowley. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation.
Conclusion
Kathleen O'Dwyer's contributions to protein characterization and purification exemplify her dedication to advancing biotechnological research. Her work continues to influence the field and pave the way for future innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile